Surviving Anaphylactoid Syndrome of Pregnancy: A Case Study

Brandon R. Healy; Susan Leclair

doi:10.29074/ascls.26.2.72

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Brandon R. Healy, MLS (ASCP)^CM⇑
1. South Shore Hospital, Weymouth, Ma
Susan Leclair, PhD
1. Department of Medical Laboratory Science, University of Massachusetts Dartmouth, Dartmouth, MA

Address for Correspondence: Brandon R. Healy MLS (ASCP)^cm, 6 Nathaniel Way, Belchertown MA, 01007, (413) 687-9468, Brandonrhealy{at}gmail.com

Abstract

Anaphylactoid Syndrome of Pregnancy (ASP) is a rare complication of delivery in mother and/or infant during the process of birth. Known as either Anaphylactoid Syndrome of Pregnancy or Amniotic Fluid Embolism, the maternal mortality rate worldwide for this complication is between 10 and 16% while the fetal mortality rate is upwards of 30%. The majority of maternal survivors are expected to have long - term neurologic deficit. While the majority of infants will survive, the majority will also incur some form of neurologic defect. This report is of a case in which both the mother and infant survived with discharge occurring at eleven days for the mother and eighteen days for the infant.

ABBREVIATIONS: ASP - Anaphylactoid Syndrome of Pregnancy, AFE - Amniotic Fluid Embolism, DIC - Disseminated Intravascular Coagulation, FFP - Fresh Frozen Plasma